IRadimed Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.33 | $0.34 | $0.34 |
| Q2 2024 | 1 | $0.36 | $0.37 | $0.37 |
| Q3 2024 | 1 | $0.40 | $0.42 | $0.41 |
| Q4 2024 | 1 | $0.43 | $0.44 | $0.44 |
| Q1 2025 | 1 | $0.41 | $0.41 | $0.41 |
| Q2 2025 | 1 | $0.43 | $0.44 | $0.44 |
| Q3 2025 | 1 | $0.45 | $0.45 | $0.45 |
| Q4 2025 | 1 | $0.45 | $0.46 | $0.46 |
IRadimed Corporation Earnings Date And Information
IRadimed Corporation last posted its earnings results on Thursday, October 31st, 2024. The company reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.04. The company had revenue of 18.33 M for the quarter and had revenue of 65.56 M for the year. IRadimed Corporation has generated $1 earnings per share over the last year ($1.35 diluted earnings per share) and currently has a price-to-earnings ratio of 34.72. IRadimed Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based on prior year's report dates.
IRadimed Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/31/2024 | Q3 2024 | $0.39 | $0.40 | 0.01 | $18.15 M | $18.33 M |
| 08/01/2024 | Q2 2024 | $0.37 | $0.39 | 0.02 | $17.65 M | $17.93 M |
| 05/02/2024 | Q1 2024 | $0.34 | $0.33 | -0.01 | $17.60 M | |
| 03/01/2024 | Q4 2023 | $0.36 | $17.45 M | |||
| 11/03/2023 | Q3 2023 | $0.36 | $0.40 | 0.04 | $16.18 M | $16.50 M |
| 08/03/2023 | Q2 2023 | $0.31 | $0.33 | 0.02 | $15.66 M | $16.13 M |
| 05/04/2023 | Q1 2023 | $0.28 | $0.27 | -0.01 | $15.48 M | |
| 03/02/2023 | Q4 2022 | $0.29 | $14.86 M | |||
| 11/03/2022 | Q3 2022 | $0.25 | $0.27 | 0.02 | $13.19 M | $13.41 M |
| 08/05/2022 | Q2 2022 | $0.26 | $12.60 M | $12.72 M | ||
| 05/06/2022 | Q1 2022 | $0.20 | $12.31 M | |||
| 03/04/2022 | Q4 2021 | $0.31 | $11.87 M | |||
| 11/05/2021 | Q3 2021 | $0.21 | $10.40 M | $10.91 M | ||
| 08/06/2021 | Q2 2021 | $0.12 | $8.46 M | $9.81 M | ||
| 05/07/2021 | Q1 2021 | $0.11 | $9.22 M | |||
| 03/05/2021 | Q4 2020 | $0.05 | $8.55 M | |||
| 11/06/2020 | Q3 2020 | $0.09 | $8.21 M | $7.70 M | ||
| 08/06/2020 | Q2 2020 | -$0.17 | $6.44 M | $6.79 M | ||
| 05/07/2020 | Q1 2020 | $0.15 | $8.68 M | |||
| 03/06/2020 | Q4 2019 | $0.28 | $10.89 M |
IRadimed Corporation Earnings: Frequently Asked Questions
-
When is IRadimed Corporation's earnings date?
IRadimed Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates.
-
Did IRadimed Corporation beat their earnings estimates last quarter?
In the previous quarter, IRadimed Corporation (:IRMD) reported $0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $0.39 by $0.04.
-
How can I listen to IRadimed Corporation's earnings conference call?
The conference call for IRadimed Corporation's latest earnings report can be listened to online.
-
How can I read IRadimed Corporation's conference call transcript?
The conference call transcript for IRadimed Corporation's latest earnings report can be read online.
-
How much revenue does IRadimed Corporation generate each year?
IRadimed Corporation (:IRMD) has a recorded annual revenue of $65.56 M.
-
How much profit does IRadimed Corporation generate each year?
IRadimed Corporation (:IRMD) has a recorded net income of $65.56 M. IRadimed Corporation has generated $1.36 earnings per share over the last four quarters.
-
What is IRadimed Corporation's price-to-earnings ratio?
IRadimed Corporation (:IRMD) has a price-to-earnings ratio of 34.72 and price/earnings-to-growth ratio is 0.35.
